Literature DB >> 18074137

Definition of disease duration in ankylosing spondylitis.

Ernst Feldtkeller1, Jon Erlendsson.   

Abstract

Two definitions of the "disease duration" of ankylosing spondylitis (AS) have been used in the literature: (1) duration since first symptoms connected with AS and (2) duration since diagnosis of AS. To investigate how useful these definitions are for research, we reinvestigated the data of four surveys completed by patients with AS in the years since 1996. We found that the majority of the patients remembered the age at first symptoms with an accuracy of <or=1 year, and that the difference between both definitions (the delay in diagnosis) was between 9.8 and 10.4 years on average, with extreme values of more than 30 years being not very seldom. Because the error made using the duration since diagnosis as "disease duration" is much larger than the inaccuracy taken into account using the duration since first symptoms, only the duration since first symptoms connected with AS should be used as definition for the term "disease duration" of AS.

Entities:  

Mesh:

Year:  2007        PMID: 18074137     DOI: 10.1007/s00296-007-0499-y

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  9 in total

1.  [Age at disease onset and delayed diagnosis of spondyloarthropathies].

Authors:  E Feldtkeller
Journal:  Z Rheumatol       Date:  1999-02       Impact factor: 1.372

2.  A comparative study of the usefulness of the Bath Ankylosing Spondylitis Functional Index and the Dougados Functional Index in the assessment of ankylosing spondylitis.

Authors:  A Spoorenberg; D van der Heijde; E de Klerk; M Dougados; K de Vlam; H Mielants; H van der Tempel; S van der Linden
Journal:  J Rheumatol       Date:  1999-04       Impact factor: 4.666

3.  Age at disease onset and diagnosis delay in HLA-B27 negative vs. positive patients with ankylosing spondylitis.

Authors:  Ernst Feldtkeller; Muhammad Asim Khan; Désirée van der Heijde; Sjef van der Linden; Jürgen Braun
Journal:  Rheumatol Int       Date:  2002-09-03       Impact factor: 2.631

4.  Determinants of hyperkyphosis in patients with ankylosing spondylitis.

Authors:  D Vosse; D van der Heijde; R Landewé; P Geusens; H Mielants; M Dougados; S van der Linden
Journal:  Ann Rheum Dis       Date:  2005-10-11       Impact factor: 19.103

5.  Prevalence and annual incidence of vertebral fractures in patients with ankylosing spondylitis.

Authors:  Ernst Feldtkeller; Debby Vosse; Piet Geusens; Sjef van der Linden
Journal:  Rheumatol Int       Date:  2005-03-11       Impact factor: 2.631

Review 6.  Scientific contributions of ankylosing spondylitis patient advocacy groups.

Authors:  E Feldtkeller; J Bruckel; M A Khan
Journal:  Curr Opin Rheumatol       Date:  2000-07       Impact factor: 5.006

7.  The national database of the German Collaborative Arthritis Centres: I. Structure, aims, and patients.

Authors:  A Zink; J Listing; C Klindworth; H Zeidler
Journal:  Ann Rheum Dis       Date:  2001-03       Impact factor: 19.103

8.  Definition of disease duration in ankylosing spondylitis: reassessing the concept.

Authors:  J C Davis; M Dougados; J Braun; J Sieper; D van der Heijde; S van der Linden
Journal:  Ann Rheum Dis       Date:  2006-02-07       Impact factor: 19.103

9.  The natural history of ankylosing spondylitis as defined by radiological progression.

Authors:  Sinead Brophy; Kirsten Mackay; Ahmed Al-Saidi; Gordon Taylor; Andrei Calin
Journal:  J Rheumatol       Date:  2002-06       Impact factor: 4.666

  9 in total
  18 in total

1.  Which clinical variables have the most significant correlation with quality of life evaluated by SF-36 survey in Croatian cohort of patient with ankylosing spondylitis and psoriatic arthritis?

Authors:  Zrinka Jajić; Ivana Rajnpreht; Nataša Kovačić; Ivan Krešimir Lukić; Vedran Velagić; Frane Grubišić; Ana Marušić; Danka Grčević
Journal:  Rheumatol Int       Date:  2011-11-08       Impact factor: 2.631

2.  Delayed diagnosis is linked to worse outcomes and unfavourable treatment responses in patients with axial spondyloarthritis.

Authors:  Mi Ryoung Seo; Hae Lim Baek; Hyun Hwa Yoon; Hee Jung Ryu; Hyo-Jin Choi; Han Joo Baek; Kwang-Pil Ko
Journal:  Clin Rheumatol       Date:  2014-09-05       Impact factor: 2.980

Review 3.  Diagnosis and classification in spondyloarthritis: identifying a chameleon.

Authors:  Astrid van Tubergen; Ulrich Weber
Journal:  Nat Rev Rheumatol       Date:  2012-03-27       Impact factor: 20.543

4.  Relationship between diagnosis delay and disease features in Moroccan patients with ankylosing spondylitis.

Authors:  Yousra Ibn Yacoub; Bouchra Amine; Assia Laatiris; Rachida Bensabbah; Najia Hajjaj-Hassouni
Journal:  Rheumatol Int       Date:  2010-11-26       Impact factor: 2.631

5.  Clinical patterns and characteristics of ankylosing spondylitis in China.

Authors:  Qiaoxia Qian; Xia Xu; Hongjun He; Hengdong Ji; Hui Zhang; Yue Ding; Sheng-Ming Dai; Yaohong Zou; Qi Zhu; Chengde Yang; Shuang Ye; Lindi Jiang; Jian-Ping Tang; Qiang Tong; Dongyi He; Dongbao Zhao; Yuan Li; Yanyun Ma; Jingru Zhou; Ziyu Yuan; Juan Zhang; Li Jin; Xiaodong Zhou; John D Reveille; Hejian Zou; Jiucun Wang
Journal:  Clin Rheumatol       Date:  2017-05-27       Impact factor: 2.980

6.  Gender differences in Iranian patients with ankylosing spondylitis.

Authors:  Abtin Shahlaee; Mahdi Mahmoudi; Mohammad Hossein Nicknam; Elham Farhadi; Sasan Fallahi; Ahmad Reza Jamshidi
Journal:  Clin Rheumatol       Date:  2013-11-28       Impact factor: 2.980

7.  Diagnosis delay in patients with ankylosing spondylitis: factors and outcomes--an Indian perspective.

Authors:  Rohit Aggarwal; Anand N Malaviya
Journal:  Clin Rheumatol       Date:  2008-12-04       Impact factor: 2.980

8.  Clinical characteristics of patients with ankylosing spondylitis in India.

Authors:  Rohit Aggarwal; Anand N Malaviya
Journal:  Clin Rheumatol       Date:  2009-07-18       Impact factor: 2.980

9.  Impact of gender, work, and clinical presentation on diagnostic delay in Italian patients with primary ankylosing spondylitis.

Authors:  F Bandinelli; G Salvadorini; A Delle Sedie; L Riente; S Bombardieri; M Matucci-Cerinic
Journal:  Clin Rheumatol       Date:  2015-08-04       Impact factor: 2.980

10.  The relationship of serum vitamin D receptor levels with disease activity and clinical parameters in patients with ankylosing spondylitis.

Authors:  Turgut Kültür; Dilek Öztaş; Dilek Keskin; Göksal Keskin; Ali İnal; Halil Kara
Journal:  Turk J Phys Med Rehabil       Date:  2019-11-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.